(Q46429285)

English

Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

scientific article published on 14 August 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

0 references

author name string

Yoshiyuki Hattori

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Kunihiro Suzuki

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Atsuko Tomizawa

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Noriko Hirama

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Toshie Okayasu

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Sachiko Hattori

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Hiroko Satoh

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Kazumi Akimoto

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Kikuo Kasai

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

publication date

14 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Cardiovascular Research

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

81

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

133-139

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

AMP-activated protein kinase signaling in metabolic regulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Impact of cilostazol on clinical and angiographic outcome after primary stenting for acute myocardial infarction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Vascular smooth muscle cell activation by glycated albumin (Amadori adducts).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Analysis of the cilostazol safety database

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Cilostazol as a Unique Antithrombotic Agent

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

The AMP-activated protein kinase pathway--new players upstream and downstream.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Identifiers

10.1093/CVR/CVN226

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46429285&oldid=2114268965"